4.7 Article

FOXP3+ T cells in uterine sarcomas are associated with favorable prognosis, low extracellular matrix expression and reduced YAP activation

期刊

NPJ PRECISION ONCOLOGY
卷 5, 期 1, 页码 -

出版社

NATURE PORTFOLIO
DOI: 10.1038/s41698-021-00236-6

关键词

-

类别

资金

  1. Swedish Cancer Society [200169F, 201128Pj, 2018/858, 2017/473]
  2. Clas Groschinskys foundation [M21139]
  3. Swedish Research Council [2019-01541]
  4. Radiumhemmets Forskningsfonder [141082]
  5. Karolinska Institutet doctoral grant [2-5586/2017]
  6. Barncancerfonden [TJ2019-0100]
  7. Jonas Soderquist's scholarship [2432019]
  8. Swedish Research Council [2019-01541] Funding Source: Swedish Research Council
  9. Formas [2019-01541] Funding Source: Formas

向作者/读者索取更多资源

This study identified immune signatures in uterine sarcomas with prognostic value, independent of tumor type, suggesting that targeting the ECM could be beneficial for future treatments. High CD8+/FOXP3+ ratio in UUS and ESS correlated with poor survival and upregulation of immunosuppressive markers.
Uterine sarcomas are rare but deadly malignancies without effective treatment. Immunotherapy is a promising new approach to treat these tumors but has shown heterogeneous effects in sarcoma patients. With the goal of identifying key factors for improved patient treatment, we characterized the tumor immune landscape in 58 uterine sarcoma cases with full clinicopathological annotation. Immune cell characterization revealed the overall prevalence of FOXP3+ cells and pro-tumor M2-like macrophages. Hierarchical clustering of patients showed four tumor type-independent immune signatures, where infiltration of FOXP3+ cells and M1-like macrophages associated with favorable prognosis. High CD8+/FOXP3+ ratio in UUS and ESS correlated with poor survival, upregulation of immunosuppressive markers, extracellular matrix (ECM)-related genes and proteins, and YAP activation. This study shows that uterine sarcomas present distinct immune signatures with prognostic value, independent of tumor type, and suggests that targeting the ECM could be beneficial for future treatments.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Spatiotemporal transcriptomic atlas of mouse organogenesis using DNA nanoball-patterned arrays

Ao Chen, Sha Liao, Mengnan Cheng, Kailong Ma, Liang Wu, Yiwei Lai, Xiaojie Qiu, Jin Yang, Jiangshan Xu, Shijie Hao, Xin Wang, Huifang Lu, Xi Chen, Xing Liu, Xin Huang, Zhao Li, Yan Hong, Yujia Jiang, Jian Peng, Shuai Liu, Mengzhe Shen, Chuanyu Liu, Quanshui Li, Yue Yuan, Xiaoyu Wei, Huiwen Zheng, Weimin Feng, Zhifeng Wang, Yang Liu, Zhaohui Wang, Yunzhi Yang, Haitao Xiang, Lei Han, Baoming Qin, Pengcheng Guo, Guangyao Lai, Pura Munoz-Canoves, Patrick H. Maxwell, Jean Paul Thiery, Qing-Feng Wu, Fuxiang Zhao, Bichao Chen, Mei Li, Xi Dai, Shuai Wang, Haoyan Kuang, Junhou Hui, Liqun Wang, Ji-Feng Fei, Ou Wang, Xiaofeng Wei, Haorong Lu, Bo Wang, Shiping Liu, Ying Gu, Ming Ni, Wenwei Zhang, Feng Mu, Ye Yin, Huanming Yang, Michael Lisby, Richard J. Cornall, Jan Mulder, Mathias Uhlen, Miguel A. Esteban, Yuxiang Li, Longqi Liu, Xun Xu, Jian Wang

Summary: Spatially resolved transcriptomic technologies enable us to study complex biological processes such as mammalian embryogenesis. However, current methods have limitations in resolution, gene capture, and field of view, which hinders their systematic application to large and three-dimensional mid- and late-gestation embryos. In this study, we developed Stereo-seq, a spatially enhanced resolution omics-sequencing method, by combining DNA nanoball-patterned arrays and in situ RNA capture. We used Stereo-seq to generate the mouse organogenesis spatiotemporal transcriptomic atlas, MOSTA, which provides single cell resolution and high sensitivity for mapping the kinetics and directionality of transcriptional variation during mouse organogenesis. By utilizing this atlas, we investigated the molecular basis of spatial cell heterogeneity and cell fate specification in developing tissues like the dorsal midbrain. Our panoramic atlas will facilitate in-depth research into long-standing questions about normal and abnormal mammalian development.
Article Multidisciplinary Sciences

Cell transcriptomic atlas of the non-human primate Macaca fascicularis

Lei Han, Xiaoyu Wei, Chuanyu Liu, Giacomo Volpe, Zhenkun Zhuang, Xuanxuan Zou, Zhifeng Wang, Taotao Pan, Yue Yuan, Xiao Zhang, Peng Fan, Pengcheng Guo, Yiwei Lai, Ying Lei, Xingyuan Liu, Feng Yu, Shuncheng Shangguan, Guangyao Lai, Qiuting Deng, Ya Liu, Liang Wu, Quan Shi, Hao Yu, Yunting Huang, Mengnan Cheng, Jiangshan Xu, Yang Liu, Mingyue Wang, Chunqing Wang, Yuanhang Zhang, Duo Xie, Yunzhi Yang, Yeya Yu, Huiwen Zheng, Yanrong Wei, Fubaoqian Huang, Junjie Lei, Waidong Huang, Zhiyong Zhu, Haorong Lu, Bo Wang, Xiaofeng Wei, Fengzhen Chen, Tao Yang, Wensi Du, Jing Chen, Shibo Xu, Juan An, Carl Ward, Zongren Wang, Zhong Pei, Chi-Wai Wong, Xiaolei Liu, Huafeng Zhang, Mingyuan Liu, Baoming Qin, Axel Schambach, Joan Isern, Liqiang Feng, Yan Liu, Xiangyu Guo, Zhen Liu, Qiang Sun, Patrick H. Maxwell, Nick Barker, Pura Munoz-Canoves, Ying Gu, Jan Mulder, Mathias Uhlen, Tao Tan, Shiping Liu, Huanming Yang, Jian Wang, Yong Hou, Xun Xu, Miguel A. Esteban, Longqi Liu

Summary: Studying tissue composition and function in non-human primates is crucial for understanding the nature of human species. This study presents a large-scale cell transcriptomic atlas of the non-human primate Macaca fascicularis, providing a vast annotated resource for studying a species closely related to humans. The atlas has been used to reconstruct cell-cell interaction networks, map the distribution of receptors for viruses causing human infectious diseases, and establish potential clinical associations with human genetic diseases.

NATURE (2022)

Article Oncology

Molecular, cellular and systemic aspects of epithelial ovarian cancer and its tumor microenvironment

Esther Schoutrop, Lidia Moyano-Galceran, Stephanie Lheureux, Jonas Mattsson, Kaisa Lehti, Hanna Dahlstrand, Isabelle Magalhaes

Summary: This article summarizes the current knowledge on the development and metastatic progression of ovarian cancer, with a specific focus on the characteristics and functions of the immunosuppressive tumor microenvironment. Additionally, current and future treatment modalities are discussed, and an overview of different experimental models used for developing novel therapies is provided.

SEMINARS IN CANCER BIOLOGY (2022)

Article Chemistry, Multidisciplinary

Mechanical Confinement and DDR1 Signaling Synergize to Regulate Collagen-Induced Apoptosis in Rhabdomyosarcoma Cells

Jordi Gonzalez-Molina, Katharina Miria Kirchhof, Bhavik Rathod, Lidia Moyano-Galceran, Maria Calvo-Noriega, Georgia Kokaraki, Astrid Bjorkoy, Monika Ehnman, Joseph W. Carlson, Kaisa Lehti

Summary: Fibrillar collagens have been found to promote cell proliferation, migration, and survival in various epithelial cancers, but their impact on soft tissue sarcoma behavior is not well understood. However, this study unexpectedly reveals that fibrillar collagen-related gene expression is associated with a favorable prognosis in rhabdomyosarcoma. By using collagen matrices with different stiffness and in vivo-like microarchitectures, the study demonstrates that DDR1 activation induces apoptosis, while integrin beta 1 promotes cell survival in 3D rhabdomyosarcoma cell cultures. Mechanistically, the collagen-induced apoptosis is a result of both DDR1-independent and synergistic DDR1-dependent TRPV4-mediated response to mechanical confinement. These findings suggest that dense microfibrillar collagen-rich microenvironments are detrimental to rhabdomyosarcoma cells through an apoptotic response orchestrated by DDR1 signaling and mechanical confinement, which may explain the preference of rhabdomyosarcoma cells to grow in and metastasize to low fibrillar collagen microenvironments such as the lung.

ADVANCED SCIENCE (2022)

Article Dermatology

Tumour Suppressor Neuron Navigator 3 and Matrix Metalloproteinase 14 are Co-expressed in Most Melanomas but Downregulated in Thick Tumours

Olga Bugaeva, Pilvi Maliniemi, Wenche S. Prestvik, Eeva Leivo, Nicolas Kluger, Alexander Salava, Sanna Virtanen, Kirsi Jantti, Olli Saksela, Kaisa Lehti, Paula Kujala, Kai Krohn, Annamari Ranki

Summary: This study examined the expression of NAV3 in relation to MMP14 in different melanoma samples. The results showed that NAV3 copy number changes were found in a majority of primary melanomas, with deletions being the most common. NAV3 was also found to be localized at the leading edge of migrating melanoma cells in vitro. Furthermore, the expression of NAV3 correlated with MMP14 in the majority of primary melanomas, but this correlation decreased in thicker tumors. These findings suggest that the lack of both NAV3 and MMP14 may promote melanoma progression.

ACTA DERMATO-VENEREOLOGICA (2023)

Article Oncology

MMP14 expression and collagen remodelling support uterine leiomyosarcoma aggressiveness

Jordi Gonzalez-Molina, Paula Hahn, Raul Maia Falcao, Okan Gultekin, Georgia Kokaraki, Valentina Zanfagnin, Tirzah Braz Petta, Kaisa Lehti, Joseph W. W. Carlson

Summary: This study explored the impact of fibrillar collagens on uterine leiomyosarcoma (uLMS) and found that uLMS tumors have low collagen density and increased expression of collagen-remodeling genes compared to uterine leiomyomas (LM).The overexpression of matrix metalloproteinase-14 (MMP14) in uLMS was found to support uLMS cell proliferation, and uLMS cells were found to be less sensitive to changes in collagen substrate stiffness. Additionally, enhanced basal yes-associated protein 1 (YAP) activity was observed in uLMS cells, which sustains their growth in low-stiffness substrates. These findings suggest that matrix remodeling and YAP may be potential therapeutic targets for uLMS.

MOLECULAR ONCOLOGY (2023)

Review Biochemistry & Molecular Biology

The extracellular matrix-immune microenvironment crosstalk in cancer therapy: Challenges and opportunities

Lara Closset, Okan Gultekin, Sahar Salehi, Dhifaf Sarhan, Kaisa Lehti, Jordi Gonzalez-Molina

Summary: Targeting the tumour immune microenvironment (TIME) by cancer immunotherapy has improved patient outcomes, but response to these treatments varies depending on the cancer type. The extracellular matrix (ECM) plays a major role in immune cell function and resistance to therapies. Both cancer therapies and TIME-ECM crosstalk have implications for tumor progression and clinical intervention. Co-targeting of ECM and TIME with oncological therapies shows promise for improving treatment outcomes.

MATRIX BIOLOGY (2023)

Meeting Abstract Medicine, Research & Experimental

Morphometric Analysis Reveals Prognostically Distinct Groups of Undifferentiated Soft Tissue Sarcomas

Valentina Zanfagnin, Okan Gultekin, Raul Maia Falcao, Kaisa Lehti, Tirzah Braz Petta, Joseph Carlson

LABORATORY INVESTIGATION (2023)

暂无数据